Articles with public access mandates - Michel ZERAHLearn more
Not available anywhere: 3
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
C Rigaud, MA Barkaoui, C Thomas, Y Bertrand, A Lambilliotte, J Miron, ...
British journal of haematology 174 (6), 887-898, 2016
Mandates: National Institute of Health and Medical Research, France
Lung function, diagnosis, and treatment of sleep‐disordered breathing in children with achondroplasia
S Julliand, M Boulé, G Baujat, A Ramirez, V Couloigner, N Beydon, ...
American journal of medical genetics Part A 158 (8), 1987-1993, 2012
Mandates: National Institute of Health and Medical Research, France
Central sleep apnea in children: experience at a single center
O Felix, A Amaddeo, JO Arroyo, M Zerah, S Puget, V Cormier-Daire, ...
Sleep medicine 25, 24-28, 2016
Mandates: National Institute of Health and Medical Research, France
Available somewhere: 8
Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis …
M Tardieu, M Zérah, B Husson, S de Bournonville, K Deiva, ...
Human gene therapy 25 (6), 506-516, 2014
Mandates: Fondazione Telethon, Italy
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood …
AK Gnekow, DA Walker, D Kandels, S Picton, G Perilongo, J Grill, ...
European journal of cancer 81, 206-225, 2017
Mandates: Cancer Research UK, Government of Italy, Children’s Cancer and Leukaemia …
Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia
D Hervé, A Philippi, R Belbouab, M Zerah, S Chabrier, ...
The American Journal of Human Genetics 94 (3), 385-394, 2014
Mandates: National Institute of Health and Medical Research, France
Intracerebral gene therapy using AAVrh. 10-hARSA recombinant vector to treat patients with early-onset forms of metachromatic leukodystrophy: preclinical feasibility and safety …
M Zerah, F Piguet, MA Colle, S Raoul, JY Deschamps, J Deniaud, ...
Human Gene Therapy Clinical Development 26 (2), 113-124, 2015
Mandates: National Institute of Health and Medical Research, France
AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A
B Gautier, H Hajjar, S Soares, J Berthelot, M Deck, S Abbou, G Campbell, ...
Nature communications 12 (1), 2356, 2021
Mandates: European Commission
Meckel’s and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandible
M Biosse Duplan, D Komla-Ebri, Y Heuze, V Estibals, E Gaudas, N Kaci, ...
Human molecular genetics 25 (14), 2997-3010, 2016
Mandates: National Institute of Health and Medical Research, France
In utero treatment of myelomeningocele with allogenic umbilical cord-derived mesenchymal stromal cells in an ovine model
L Guilbaud, A Dugas, M Weber, C Deflers, P Lallemant, T Lilin, C Adam, ...
Current Research in Translational Medicine 70 (1), 103314, 2022
Mandates: National Institute of Health and Medical Research, France
Long term AAV2/9-mediated silencing of PMP22 prevents CMT1A disease in rats and validates skin biomarkers as treatment outcome measure
B Gautier, H Hajjar, S Soares, J Berthelot, M Deck, S Abbou, G Campbell, ...
bioRxiv, 2020.01. 29.924605, 2020
Mandates: European Commission
Publication and funding information is determined automatically by a computer program